ASND•benzinga•
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
Summary
Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 4, 2024 by benzinga